GAUTHAM COLLEGE OF PHARMACY

1. Alesso, L. (2007) Farmacovigilancia: HaciaUna Mayor Seguridad en el Uso de Medicamentos, Los talleresgráficos de  Alejandro Graziani S.A. (2nd edition planned)
2. Aronson, JK. (ed.) (2006) Meyler's Side Effects of Drugs, 15th edition, Elsevier Science.
3. Aronson, JK. (ed.) (2010) Side Effects of Drugs Annual (36), Elsevier.
4. Baxter, K. (ed.) (2010) Stockley's Drug Interactions, 9th edition, Pharmaceutical Press.
5. Begaud, B. (2000) Dictionary of Pharmacoepidemiology, John Wiley & Sons Ltd.
6. Bennett, P., Calman, K., Curtis, S. and Fischbacher-Smith, D. (2010) Risk Communication and Public Health, 2nd edition, Oxford University Press, USA.
7. BMJ. (2007) Clinical Evidence Handbook: The International Source of the Best Available Evidence for Effective Healthcare, BMJ Publishing Group.
8. CIOMS. (1999) Benefit-Risk Balance for Marketed Drugs: Evaluating Safety Signals (Report of CIOMS Working Group IV), WHO.
9. CIOMS. (2010) Practical Aspects of Signal Detection in Pharmacovigilance (Report of CIOMS Working Group VIII), WHO.
10. Cobert, B. (2011) Cobert’s Manual of Drug Safety and Pharmacovigilance, 2nd edition, Jones & Bartlett Learning.
11. Cobert, B. and Biron, P. (2008) Practical Drug Safety from A to Z, Jones & Bartlett Publishers.
12. Cohen, MR. (2006) Medication Errors, 2nd edition, American Pharmacists Association.
13. Dukes, G., Mildred, M. and Swartz, B. (1998) Responsibility for Drug-Induced Injury: A Reference Book for Lawyers, the Health Professions and Manufacturers, IOS Press.
14. Gupta, SK. (ed.) (2011) Textbook of Pharmacovigilance, Jaypee Brothers Medical Publishers (P) Ltd.
15. Hugman, B. (2009) Healthcare Communication, Pharmaceutical Press.
16. Klepper, MJ. and/Cobert, B. (2010) Drug Safety Data: How to Analyze, Summarize, and Interpret to Determine Risk, Jones & Bartlett Learning.
17. Klincewicz, SL., Yap, YY., Thomas, A. with Taylor, JL. (ed.) (2009) Global Pharmacovigilance: Laws & Regulations, the Food and Drug Law Institute.
18. Mann, RD. and Andrews, EB. (ed.) (2007) Pharmacovigilance, 2nd edition, John Wiley & Sons Ltd.
19. MHRA. (2008) Good Pharmacovigilance Practice Guide, Pharmaceutical Press.
20. Slovic, P. (2000) The Perception of Risk, Earthscan Publications Ltd.
21. Strom, BL. (2005) Pharmacoepidemiology, 4th edition, John Wiley & Sons Ltd.
22. Sweetman, SC. (ed.)(2011) Martindale: The Complete Drug Reference, 37th edition, Pharmaceutical Press.
23. Talbot, J. and Waller, P. (ed.) (2003) Stephen’s Detection of New Adverse Drug Reactions, 5th edition, John Wiley & Sons Ltd.
24. Van Boxtel, CJ.,Santoso, B. and Edwards, IR. (ed.) (2008) Drug Benefits and Risks: International Textbook of Clinical Pharmacology, 2nd edition, IOS Press.
25. Vincent, C. (2010) Patient Safety, 2nd edition, Wiley-Blackwell.
26. Waller, P. (2009) An Introduction to Pharmacovigilance, Wiley-Blackwell.